Deep Cultural Understanding
We help you connect with Asia's diverse cultures by navigating local habits, values, and unspoken norms. This ensures your strategy aligns with local expectations, building trust and fostering sustainable results.
Asia Life Science Consulting
With decades of expertise, our Asia Life Science Consulting firm excels in navigating the Asia life science industry. We empower clients to thrive in Asia's competitive market through a wide range of services and a hands-on support approach, backed by our global reach.
Asia Macroeconomic Overview
Asia’s life sciences sector is supported by robust macroeconomic growth across the region, with developing Asia’s GDP projected at 5.1 % in 2025 and moderating slightly to 4.6 % in 2026. This expanding economic backdrop underpins rising demand for healthcare innovation, R&D investment, and structural industry expansion in life sciences.
The APAC life science market is valued at approximately US $17.51 billion in 2024 and is expected to grow to US $19.46 billion by 2025, with a forecasted CAGR of 12.1 % through 2034, reaching US $54.81 billion. Country-level expansion is led by China, which holds about 35 % of the regional market in 2024, while instruments dominate product segments (~48 %) and genomics leads by technology (~43 %).
Analytical tools within life sciences are rising rapidly: Asia Pacific’s life science analytics market is projected at US $9.96 billion in 2025, expanding at a CAGR of 12.8 % to approximately US $18.15 billion by 2030. Major contributors include Japan (US $4.41 billion), China (US $3.86 billion), and India (US $1.54 billion), reflecting sustained investment in genomics R&D, regulatory digitalization, and precision-medicine infrastructure.
The APAC life science market is forecasted to grow at a CAGR of
12.1%
Source: Asian Development Outlook (ADO) December 2025: Growth Steadies But Uncertainty Lingers | Asian Development Bank
Our Life Science Expertise in Asia
Asia's life science landscape is dynamic, encompassing pharmaceuticals, biotechnology, medical devices, diagnostics, healthcare IT, genomics, personalized medicine, biopharmaceuticals, nutraceuticals, telemedicine, health analytics, regenerative medicine, clinical trials, bioinformatics, and healthcare infrastructure. As these sectors evolve, they are driven by innovations such as AI integration, increased digitalization, and enhanced patient-centric approaches.
Our firm offers unparalleled life science consulting tailored to navigate this complex landscape. We provide insights into regulatory frameworks, market dynamics, and competitive strategies, ensuring that organizations are poised for sustainable growth and innovation. By leveraging our expertise, clients gain critical advantages in an ever-changing market environment.
Trends like precision medicine, AI-driven drug discovery, and sustainable healthcare solutions reshape the industry landscape. Partnering with us empowers clients to anticipate these shifts strategically. We ensure that decision-makers can seize opportunities and tackle challenges effectively, driving their organizations towards robust success in the vibrant Asia life science arena.
Our Proven Local Know How
Data-Driven Market Intelligence
Our actionable intelligence, powered by real-time market monitoring and insights from your ecosystem, enables you to make informed decisions, seize emerging opportunities, and mitigate risks in Asia's dynamic markets.
Authentic Local Insights
Through direct engagement with key stakeholders, we provide you with nuanced perspectives that reveal the “why” behind market behaviors, helping you design tailored solutions that drive meaningful results.
Turn Life Science Insight into Stronger Decisions in Asia
Validate opportunities, manage risk, and allocate capital with greater confidence through current market evidence and practical strategic advice.
How We Help
Our company has successfully supported various Life Science projects by providing market research, competitive analysis, and strategic guidance to help businesses succeed.
Market Research
We offers comprehensive Life Science market research, delivering valuable insights and actionable recommendations in Asia to enable businesses to make well-informed decisions and achieve long-term success in the industry.
Strategic Planning
We offers comprehensive Life Science Strategic Planning services in Asia, providing tailored frameworks and actionable strategies to help businesses achieve their goals and sustain growth in a competitive environment.
Market Entry
We delivers expert Life Science Market Entry Strategy solutions in Asia, offering valuable insights and effective approaches that empower businesses to successfully penetrate new markets and secure a competitive edge.
Mergers and Acquisitions
We provides in-depth Life Science Merger and Acquisitions advisory in Asia, guiding businesses with expert recommendations to navigate complex transactions, unlock synergies, and maximize shareholder value.
Value Chain Analysis
We specializes in Life Science Value Chain Analysis in Asia, delivering actionable insights that optimize operational efficiency, enhance profitability, and drive strategic decision-making for businesses across industries.
Competitive Benchmarking
We offers thorough Life Science Competitive Benchmarking services in Asia, helping businesses identify key performance gaps, uncover market opportunities, and build stronger competitive strategies.
Distribution & Strategic Partnership
We delivers expert Life Science Distribution and Strategic Partnership solutions in Asia, enabling businesses to establish effective networks, foster collaborative relationships, and achieve long-term market success.
Consumer Behavior Analysis
We provides advanced Life Science Consumer Behavior Analysis services in Asia, offering actionable insights into consumer preferences and trends to help businesses refine their strategies and enhance customer satisfaction.
Our Experts
Establish industry dominance with our experts and partners
Damien Duhamel
Managing Partner
Market Research, Strategy & Market Expansion
Grégoire Virat
Managing Partner
Business Transformation, Digital Innovation & International Growth
Mickael Feige
Partner
Market Research, Market Entry & Growth Strategy
Jack Fowler
Principal
Growth Strategy, Regional Market Assessment & Market Expansion
Dian Kuncoro
Director
Digital Transformation, Data & Technology Strategy
Our Presence in Media & Events
SOUTH CHINA MORNING POST
South China Morning Post featured Damien Duhamel, Managing Partner at Eurogroup Consulting, sharing his perspective on how Chinese EV competition could reshape Malaysia's automotive industry and the wider regional market.
TRANSPORT LOGISTIC SEA 2025
At Transport Logistic Southeast Asia 2025, Mickael Feige, Partner at Eurogroup Consulting, moderated a fireside chat on building seamless, smart and sustainable supply chains for the new global economy.
BUSINESS INSIDER
Damien Duhamel shared his perspective with Business Insider on the factors shaping innovation across Asia's leading cities, from human talent and technology to governance and global integration.
Our Publications
Download Whitepaper
Senior Living in Thailand
Thailand’s ageing transition is creating a real but selective senior living opportunity. The paper examines investable demand, scalable business models and the constraints still limiting market growth.
Download Whitepaper
Rising Tides in the East
Southeast Asia is emerging as a key advanced manufacturing hub. The white paper examines the capabilities, technologies and opportunities reshaping the region’s industrial landscape.
Download Whitepaper
Future Asean Sustainable Cities
Southeast Asia’s cities are transforming through rapid urbanisation and sustainability. It explores the trends shaping greener, more resilient and inclusive urban development.
Download Whitepaper
The New Asean Consumer
ASEAN’s consumer landscape is evolving with rising incomes, digitalisation and changing expectations. The report highlights the trends reshaping how businesses engage and grow across the region.
Case Studies
Regulatory Pathway Optimization — Biotechnology Product Launch
Leading biotech innovator — Asia-wide market entry
VIEW DETAILHIDE DETAIL
→
Challenge
The client faced complex regulatory challenges in launching a new biotechnology product across multiple Asian markets. Barriers included varying compliance requirements and stringent timelines impacting their go-to-market strategy. A targeted approach was essential to streamline the approval process.
Our Intervention
We developed a comprehensive regulatory strategy that included gap analyses for each market, coordination with regulatory bodies, and crafting tailored compliance documentation. Our team provided hands-on support with dossier preparation, ensuring alignment with local policies.
Key Recommendations
We recommended an integrated compliance framework to harmonize submissions and reduce approval times, along with a phased market entry strategy to manage risks. Our approach emphasized proactive stakeholder engagement and cross-functional readiness.
Projected Business Impact
The launch timeline was reduced by 30%, and compliance costs were lowered by 20% relative to initial projections. Regulatory approval was achieved on time, enabling quicker market access and revenue generation.
R&D Efficiency Enhancement — Pharmaceutical Development
Major pharmaceutical company — regional R&D overhaul
VIEW DETAILHIDE DETAIL
→
Challenge
The client struggled with inefficiencies in their R&D processes, affecting timelines and innovation output across Asian facilities. Disparate systems and siloed teams led to delays and misalignment in project priorities. An urgent need for process optimization was identified.
Our Intervention
We conducted a detailed assessment of current workflows, technology integration, and resource allocation. Our team implemented agile methodologies and advanced project management tools to streamline operations and foster collaboration.
Key Recommendations
Recommendations focused on centralizing data management, enhancing cross-departmental communication, and adopting AI-driven analytics to predict project success. We prioritized establishing a culture of continuous improvement and innovation.
Projected Business Impact
Development cycle times improved by 25%, and project initiation costs were reduced by 15%. Enhanced R&D productivity led to a 10% increase in successful project completions year-on-year.
Market Expansion Strategy — Medical Devices Sector
Emerging medtech company — expanding footprint in Southeast Asia
VIEW DETAILHIDE DETAIL
→
Challenge
The client aimed to expand their market presence in Southeast Asia but faced challenges with market penetration and competitive differentiation. Diverse regulatory landscapes and distribution barriers posed significant obstacles. Strategic alignment was critical for success.
Our Intervention
We devised a comprehensive market entry strategy, conducted competitive analysis, and facilitated strategic partnerships with local distributors. Efforts included aligning product offerings with regional healthcare needs and regulatory compliance.
Key Recommendations
Our key recommendations involved leveraging local expertise for market intelligence, tailored marketing campaigns, and developing adaptable pricing strategies. Focus was placed on regulatory fluency and strategic channel management.
Projected Business Impact
Market share increased by 12% within two years, and distribution efficiency improved by 35%. The client's brand recognition and customer base grew significantly, establishing a solid foundation for future expansion.
Our Clients
Trusted by clients for long-term collaboration. Selected organizations our teams have supported globally and across Asia.
Frequently Asked Questions
What does a market study in the Asian life science industry cover? +
A market study in Asia's life science sector includes demand analysis, client segmentation, regulatory review, and competitor benchmarking. It aims to understand market dynamics, evaluate growth opportunities, and assess consumer needs. This provides a detailed overview necessary for strategic decision-making.
Why is a feasibility study crucial before entering the Asian market? +
A feasibility study determines viability by analyzing economic, technical, and legal aspects. It involves market demand assessment, financial modeling, operational requirements evaluation, and risk analysis. Conducting this ensures informed choices about investments and helps avoid potential market entry pitfalls.
How is market size assessed in the Asian life science sector? +
Market size is assessed through demand forecasting, trend analysis, and reviewing historical data, combined with field interviews and stakeholder surveys. This process helps determine the potential customer base and revenue opportunities, providing insight for strategic planning and resource allocation.
How do consultants conduct competitive analysis in Asia's life science market? +
Competitive analysis involves examining competitor products, pricing strategies, market positioning, and innovation trends. This is achieved through data collection, competitor benchmarking, and qualitative interviews, allowing businesses to understand competitive dynamics and identify strategic advantages.
What methods are used in Asia for regulatory compliance in life sciences? +
Regulatory compliance involves understanding regional regulations, conducting compliance audits, and consulting with legal experts. Consultants perform document reviews and partner with local regulatory bodies to ensure adherence. This process helps navigate the complex regulatory environment efficiently and effectively.
CONTACT US
Speak to advisors that have experience in the Asia Life Science market
info@marketresearchsoutheastasia.com600 N Bridge Rd, #13-06, Singapore 188778
FOLLOW US